리나디엠메트서방정2.5/1000밀리그램(리나글립틴|메트포르민)
Recall Summary Linagliptin/Metformin extended-release tablets 2.5/1000mg manufactured by Dongwha Pharmaceutical are being recalled in South Korea due to detection of N-nitroso-meglumine impurity levels exceeding permitted standards. This is a Class II recall affecting the specific barcodes listed. The manufacturer is conducting a voluntary recall of the product.
- Recalling firm
- 동화약품(주)
- Product
- 리나디엠메트서방정2.5/1000밀리그램(리나글립틴|메트포르민) (Barcode: 8806427075605, 8806427075612)
- Reason
- 불순물(N-nitroso-meglumine)허용기준초과검출에따른영업자회수
- Classification
- Class II
- Category
- drug recall
- Country
- South Korea
- Agency
- MFDS-DRUG
- Recall date
- 2026-07-02
- Status
- Ongoing
- Distribution
- South Korea
Official recall notice from MFDS-DRUG
Recall details on Nibble Recalls: https://trynibble.app/recalls/e02c67f4-7d49-4859-badc-0cff9988aea4